Date | Name | Activity | Value |
---|---|---|---|
Dec 30, 2024 | James L. Tyree Director | xxxxxxxxxxxxx | $8512 |
Dec 18, 2024 | Joseph Cappello Vp, Pharmaceutical Development | xxxxxxxxxxxxx | $14742 |
Sep 13, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $171118 |
Sep 11, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $196503 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
3,413,581 | Insider | 9.90% | 7,817,100 | |
1,165,886 | Institution | 3.38% | 2,669,879 | |
963,919 | Institution | 2.79% | 2,207,375 | |
631,307 | Institution | 1.83% | 1,445,693 | |
505,501 | Insider | 1.46% | 1,157,597 | |
200,131 | Institution | 0.58% | 458,300 | |
171,872 | Insider | 0.50% | 393,587 | |
82,452 | Insider | 0.24% | 188,815 | |
65,930 | Institution | 0.19% | 150,980 | |
63,467 | Institution | 0.18% | 145,339 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
963,919 | Institution | 2.79% | 2,207,375 | |
200,131 | Institution | 0.58% | 458,300 | |
25,224 | Institution | 0.07% | 57,763 | |
13,500 | Institution | 0.04% | 30,915 | |
7,125 | Institution | 0.02% | 16,316 | |
5,541 | Institution | 0.02% | 12,689 | |
553 | Institution | <0.01% | 1,266 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
873,800 | Institution | 2.53% | 2,350,522 | |
292,086 | Institution | 0.85% | 785,711 | |
65,930 | Institution | 0.19% | 157,573 | |
63,467 | Institution | 0.18% | 145,339 | |
2,248 | Institution | <0.01% | 45,275 |